-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ib138dpV285GbzLmVB0Noi+pQAHgyEuPpLE/5YmQONHGeLV6acIFiUnMe107mvKv o20zJXAQbyrca93HVsjC4Q== 0001193125-09-132431.txt : 20090617 0001193125-09-132431.hdr.sgml : 20090617 20090617155450 ACCESSION NUMBER: 0001193125-09-132431 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090612 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20090617 DATE AS OF CHANGE: 20090617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOPTIX INC CENTRAL INDEX KEY: 0001138412 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 330840570 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33753 FILM NUMBER: 09896609 BUSINESS ADDRESS: STREET 1: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-268-6200 MAIL ADDRESS: STREET 1: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 12, 2009

 

 

GENOPTIX, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-33753   33-0840570

(State or other jurisdiction of

incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

1811 Aston Avenue

Carlsbad, CA 92008

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (760) 268-6200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement.

On June 12, 2009, Genoptix, Inc., a Delaware corporation (“Genoptix”) entered into a lease agreement with the Reynolds Family Trust (“Reynolds”), for approximately 44,000 square feet of office and laboratory space in Carlsbad, California. The six-year term of the lease commenced on June 1, 2009 (the “Effective Date”), and Reynolds has granted Genoptix an option to extend the term of the lease for an additional four-year term (the “Option Term”). Under the lease, the minimum monthly rent payable is approximately $44,000 during the first year of the lease, which will increase by three percent (3%) on each anniversary of the Effective Date during the six year term of the lease. In the event Genoptix chooses to extend the term of the lease beyond the initial six-year term, the minimum monthly rent payable will be increased to approximately $53,000 in the first year of the Option Term and will continue to increase by three percent (3%) on each anniversary of the Effective Date through the fourth year of the Option Term.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      GENOPTIX, INC.
Dated: June 17, 2009       By:   

/s/    Christian V. Kuhlen, M.D., Esq.

         Christian V. Kuhlen, M.D., Esq.
         Vice President, General Counsel
-----END PRIVACY-ENHANCED MESSAGE-----